inclusion criteria: 1. adults from 18 to 60 years old who signed informed consent; 2. laboratory confirmed sars-cov-2 infection by real-time rt-pcr. 3. chest computed tomography (ct) imaging-confirmed lung damage, including multiple small plaques and stromal changes in the lungs, which are obvious in the outer lung, or multiple ground-glass shadows and infiltration shadows in both lungs, although these changes might not be present in mild patients. 4. patients with history of fever (axillary temperature more than 37°с) or respiratory symptoms.

inclusion criteria: 1. adults from 18 to 60 years old who signed informed consent; 2. laboratory confirmed sars-cov-2 infection by real-time rt-pcr. 3. chest computed tomography (ct) imaging-confirmed lung damage, including multiple small plaques and stromal changes in the lungs, which are obvious in the outer lung, or multiple ground-glass shadows and infiltration shadows in both lungs, although these changes might not be present in mild patients. 4. patients with history of fever (axillary temperature more than 37°с) or respiratory symptoms.

inclusion criteria: adults from 18 to 60 years old who signed informed consent; laboratory confirmed sars-cov-2 infection by real-time rt-pcr. chest computed tomography (ct) imaging-confirmed lung damage, including multiple small plaques and stromal changes in the lungs, which are obvious in the outer lung, or multiple ground-glass shadows and infiltration shadows in both lungs, although these changes might not be present in mild patients. patients with history of fever (axillary temperature more than 37°с) or respiratory symptoms.

inclusion criteria: adults from 18 to 60 years old who signed informed consent; laboratory confirmed sars-cov-2 infection by real-time rt-pcr. chest computed tomography (ct) imaging-confirmed lung damage, including multiple small plaques and stromal changes in the lungs, which are obvious in the outer lung, or multiple ground-glass shadows and infiltration shadows in both lungs, although these changes might not be present in mild patients. patients with history of fever (axillary temperature more than 37°с) or respiratory symptoms.

inclusion criteria: 1. adults from 18 to 60 years old who signed informed consent; 2. laboratory confirmed sars-cov-2 infection by real-time rt-pcr. 3. chest computed tomography (ct) imaging-confirmed lung damage, including multiple small plaques and stromal changes in the lungs, which are obvious in the outer lung, or multiple ground-glass shadows and infiltration shadows in both lungs, although these changes might not be present in mild patients. 4. patients with history of fever (axillary temperature more than 37°с) or respiratory symptoms.

inclusion criteria: 1. adults from 18 to 60 years old who signed informed consent; 2. laboratory confirmed sars-cov-2 infection by real-time rt-pcr. 3. chest computed tomography (ct) imaging-confirmed lung damage, including multiple small plaques and stromal changes in the lungs, which are obvious in the outer lung, or multiple ground-glass shadows and infiltration shadows in both lungs, although these changes might not be present in mild patients. 4. patients with history of fever (axillary temperature more than 37°с) or respiratory symptoms.